T1	intervention 70 90	photodynamic therapy
T3	total-participants 324 326	40
T4	control 406 414	RT alone
T5	control-participants 427 429	20
T6	intervention-participants 472 474	20
T7	outcome 617 631	response rates
T8	iv-bin-percent 749 752	50%
T9	cv-bin-percent 771 774	20%
T10	outcome 781 798	median time to CR
T11	outcome 895 917	Adverse event profiles
T12	iv-cont-median 858 868	109.6 days
T13	cv-cont-median 873 883	175.2 days
T2	eligibility 327 364	patients with recurrent breast cancer
